HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Correction of erectile dysfunction in patients with chronic abacterial prostatitis].

Abstract
A total of 76 patients with chronic abacterial prostatitis (CAP) in combination with erectile dysfunction were divided into two groups. Clinical symptoms of CAP and severity of erectile dysfunction were the same in both groups. Patients of the study group (n = 36) received pathogenetic treatment (vitaprost plus physiotherapy) and impase. The control group (n = 40) received vitaprost and physiotherapy. The results of the treatment showed that impase addition to combined treatment of CAP patients with erectile dysfunction significantly improves erectile function: 80.6% patients given impase raised their score by International Index of Erectile Function Scale to normal (26 points and higher). Impase efficacy increased with prolongation of the treatment from 4 to 12 weeks.
AuthorsV N Tkachuk, S Kh Al'-Shukri, I N Tkacuk, V I Kornienko
JournalUrologiia (Moscow, Russia : 1999) (Urologiia) 2011 Nov-Dec Issue 6 Pg. 29-31 ISSN: 1728-2985 [Print] Russia (Federation)
PMID22448477 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Peptides
  • Vitaprost
Topics
  • Adult
  • Chronic Disease
  • Erectile Dysfunction (complications, therapy)
  • Humans
  • Male
  • Peptides (administration & dosage)
  • Physical Therapy Modalities
  • Phytotherapy
  • Prostatitis (complications, therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: